Syn Oss Unique Form of the granules mimics the macro-structure of bone.
The pores of this matrix material connect one to another to form continuos
uniform channels with no dead ends.
The interconnected pores provide optimal permeability that encourages
angiogenesis and deposition of new bone.
Syn Oss the supersafe / predictable bone regenerator
Pure phase Beta tricalcium Phosphate
No risk of disease transmission
No immunogenic reactions
Syn Oss Synthesised from highly pure chemical raw materials and exposed
to temperatures of over 1000 C during production this safetly excludes
all risk of infection.
Physiologic pH value
Does not influence the physiological Ph value of tissues in the implanted
Shelf life +++
No chemical changes or degradation if stored in dry room temperature
Syn Oss is indicated for filling of mostly non-stressed, multiple bone defects
of the skeleton. The augmentation site should be free of inflamation, soft
tissue, granulation tissue & infection. Indications include :
The speed of degradation of Syn Oss = Rate of bone formation Degrades
fully within 6 - 12 months, depending upon regeneration dynamics of the
Post extraction ridge preservation
Periodontal bone defects
Bone defects after removal of cysts
Bone defects after removal of impacted teeth
Sinus floor elevation surgery
Peri implant defects
Defects after harvesting autogenous bone
Bone Substitute thats Osteopromotive
Sizes 300 - 600 µ medium a small defects.
600 - 1000 µ large defects and sinus
Pkg 0.5gm, 1.5gms
Specific surface area of bone substitute
material (m /g) for Synoss 1.5 m /g
Meets purity requirements for bioceramics
of the American Standard ASTM F 1088-87.
Produced by a special sintering process
resulting in optimal particle size and porosity.
When used with autogenous bone 50:50
the biomechanical stability of the bone
site is guaranteed by the additional inductive
property of autogenous bone.
Can be used with PRP with excellent results.
Syn Oss when moist the granules adhere facilitating placement. Use either
autogenous blood from surgical site or sterile isotonic saline solution.
Latest developments and case studies are Next